IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

M28 Capital Management LP

Q3 2024 Holdings

Filed 2024-11-12 | 11 holdings | $91.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Wave Life Sciences LTD(WVE)SHSY95308105$50.5M6,164,54855.5%
Invivyd Inc(IVVD)COM00534A102$9.4M9,248,25010.4%
Rocket Pharmaceuticals Inc(RCKT)COM77313F106$7.1M385,6807.8%
Fractyl Health Inc(GUTS)COM35168W103$4.7M1,856,1175.2%
TG Therapeutics Inc(TGTX)COM88322Q108$3.8M161,6004.2%
Springworks Therapeutics IncCOM85205L107$3.5M110,4003.9%
Silence Therapeutics PLC(SLN)ADS82686Q101$3.4M185,1003.7%
Bridgebio Pharma Inc(BBIO)COM10806X102$3.1M121,2003.4%
Curis Inc(CRIS)COM231269309$2.3M421,9512.5%
Proqr Thrapeutics N VSHS EURON71542109$1.9M1,019,4982.0%
Arrowhead Pharmaceuticals in(ARWR)COM04280A100$1.3M67,4001.4%